The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products. The development and production of biologics can be a complex process.

Continuous manufacturing and a quality-by-design development approach are a natural fit. FDA, as well as other regulatory agencies around the world, have for many years been encouraging drug makers to ...

LIVINGSTON, UNITED KINGDOM--(Marketwired - Nov 29, 2016) - memsstar Limited announced today that it has installed two ORBIS ALPHA systems in Bosch's German research and development facility in ...

Semiconductor logic and memory technology development continues to push the limits of process complexity and cost, especially as the industry migrates to the 5 nm node and beyond. Optimization of the ...

Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...

Upstream Process Development (UPD) is essential to ensure robust, scalable processes that can efficiently bring biotherapeutics to market. However, challenges such as optimizing yield, ensuring ...

he need for effective government technology products in Indonesia cannot be overstated, particularly as the nation's existing plethora of digital solutions has yet to deliver the demanded ...

One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

Honeywell and Danfoss are partnering to integrate variable frequency drive (VFD) technology with Honeywell's Experion Process Knowledge System platform to streamline motor control, reduce energy ...